Viemed Healthcare, Inc.
VMDHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Viemed Healthcare, Inc. focuses on Medical Devices services and products. Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. With a market capitalization of $363.4M, it sits in small-cap territory. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Market Cap
$363.4M
Beta
1.15
P/E (TTM)
25.62
P/E (Fwd)
23.70
EPS (TTM)
$0.37
EPS (Fwd)
$0.40
ROE
10.9%
ROA
8.3%
Cash
$9.8M
Total Debt
$12.4M
Free CF
$28.3M
52W Change
38.0%
Annual Financials
Cash vs Debt
The company holds $9.8M in cash, though total debt stands at $12.4M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $28.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 10.9% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $138.8M (2022) to $270.3M (2025), reflecting a 95% increase over the period.
Investors considering Viemed Healthcare, Inc. should weigh the typical risks associated with VMD's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing VMD's risk profile alongside its fundamentals and technical indicators provides a more complete picture.